Ellen Jorgensen

Last updated

Ellen D. Jorgensen [1] (born 2 June 1955) is a New York-based molecular biologist and serial entrepreneur. In addition to her long career in the biotechnology industry she is also credited with playing a leading role in promoting the do-it-yourself biology movement where she has worked to increase scientific literacy in the general population, particularly in the fields of molecular and synthetic biology. [2] [3] She is a co-founder of both non-profit (Biotech Without Borders [4] and Genspace. [2] ) and for-profit (Aanika Biosciences [5] ) biotechnology-based companies. In 2017, Ellen Jorgensen was named one of the Most Creative Leaders in Business by Fast Company. [3] Her current focus is on combating climate change through her role as Vice President of Biotechnology at CarbonBridge, a biotech startup that uses bacteria to remove environmental methane and create liquid fuel [6] .

Contents

Education and career

Ellen Jorgensen graduated from New York University (NYU) in 1977 with a B.A. in Biology. She then went on to earn both her MA and MPhil in Biological Sciences from Columbia University in 1979 and 1981, respectively. [7] Jorgensen returned to NYU where she obtained her Ph.D. in Cell and Molecular Biology in 1987 from the Sackler Institute. [8] She later went to SUNY Downstate as a post-doc to continue research in protein structure and function. [8] Jorgensen has served as adjunct faculty at The Cooper Union in New York City [2] , New York Medical College and at the School of Visual Arts. [9]

Jorgensen devoted many years of her career to various positions at both nonprofit and for-profit companies within the biotechnology sector. [8] She spent eight years, from 2001 to 2009, as the Director of Biomarker Discovery and Development at Vector Research, researching early biomarkers of tobacco-related lung disease. [8] In 2009, she co-founded the community biohacker space, Genspace [10] where she developed innovative programming such as the Biorocket internships for underserved New York City high school students and classes in genetic engineering for the general public. Under her leadership Genspace provided low-cost lab space for biotech entrepreneurs [11] . Opentrons and Curieco both used the Genspace pre-incubator space to launch successful companies. In 2017, Jorgensen founded Biotech Without Borders, a second nonprofit community biotechnology lab where she continues to serve on the board of directors. [3]

In 2009, Ellen Jorgensen co-founded Genspace, the first nonprofit community biotech lab. In 2010, Jorgensen initiated Genspace's curriculum of informal science education, leading to the company being named one the World's Top 10 Innovative Companies in Education. [2] [12] [13] The goal of Genspace is to increase scientific literacy in the general public by providing classes and workshops, as well as a space for community members to get involved in a biotechnology laboratory. [14] In March 2017, Ellen Jorgensen stepped down from her role as executive director to found Biotech Without Borders and was replaced by Genspace co-founder, Daniel Grushkin. [15] Jorgensen became president emeritus. [15]

While Genspace was created with the goal of making scientific literacy more accessible, the organization was met with criticism by those that felt that hands-on science should be left to the professionals. [14] Despite this criticism, Genspace has continued on, along with a larger community of hacker spaces opening worldwide, fostering an open environment of scientific collaboration and learning between amateurs and professionals. [14] [10]

Genspace is located in Brooklyn, New York. The lab follows Biosafety Level 1 restrictions. [16] Different membership tiers are offered providing access to events, classes, lab access, participation to community projects, and more. [17] In the spring of 2018, community projects will be offered in the fields of mycoremediation, open plant collaboration, and optogenetics. [18]

Accolades

Biotech Without Borders

In 2017, Ellen Jorgensen stepped down from her leadership role at Genspace in order to found Biotech Without Borders, where she now acts as President. [3] [2] Biotech Without Borders is a Brooklyn, New York based nonprofit public charity dedicated to enabling communities underrepresented in the biotechnology field to gain hands-on biotech lab experience. [20] Biotech Without Borders focuses on providing a Biosafety Level 2 lab space, distributing biotech resources to labs worldwide, and engaging the public through hands-on lab classes, workshops, and events. [21] It is the first Biosafety Level 2 lab open for public projects. Compared to Genspace, Biotech Without Borders seeks to facilitate engagement with more authentic high-level science.

Selected publications

Related Research Articles

<span class="mw-page-title-main">Flow cytometry</span> Lab technique in biology and chemistry

Flow cytometry (FC) is a technique used to detect and measure the physical and chemical characteristics of a population of cells or particles.

Daclizumab is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis (MS). Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells.

Pharming, a portmanteau of farming and pharmaceutical, refers to the use of genetic engineering to insert genes that code for useful pharmaceuticals into host animals or plants that would otherwise not express those genes, thus creating a genetically modified organism (GMO). Pharming is also known as molecular farming, molecular pharming, or biopharming.

DNA fragmentation is the separation or breaking of DNA strands into pieces. It can be done intentionally by laboratory personnel or by cells, or can occur spontaneously. Spontaneous or accidental DNA fragmentation is fragmentation that gradually accumulates in a cell. It can be measured by e.g. the Comet assay or by the TUNEL assay.

BiOS is an international initiative to foster innovation and freedom to operate in the biological sciences. BiOS was officially launched on 10 February 2005 by Cambia, an independent, international non-profit organization dedicated to democratizing innovation. Its intention is to initiate new norms and practices for creating tools for biological innovation, using binding covenants to protect and preserve their usefulness, while allowing diverse business models for the application of these tools.

<span class="mw-page-title-main">Health effects of tobacco</span> Circumstances, mechanisms, and factors of tobacco consumption on human health

Tobacco products, especially when smoked or used orally, have serious negative effects on human health. Smoking and smokeless tobacco use is the single greatest cause of preventable death globally. As many as half of people who smoke tobacco or use it orally die from complications related to such use. It has been estimated that each year, in total about 6 million people die from tobacco-related causes, with 600,000 of these occurring in non-smokers due to secondhand smoke. It is further estimated to have caused 100 million deaths in the 20th century.

<span class="mw-page-title-main">Henry I. Miller</span> American medical researcher and columnist

Henry I. Miller is an American medical researcher and columnist, formerly with the FDA, and from 1994 until 2018 the Robert Wesson Fellow in Scientific Philosophy and Public Policy at Stanford University's Hoover Institution, a public policy think tank located on the university's campus in California. He is an Adjunct Fellow of the Competitive Enterprise Institute.

<span class="mw-page-title-main">Genetically modified plant</span> Plants with human-introduced genes from other organisms

Genetically modified plants have been engineered for scientific research, to create new colours in plants, deliver vaccines, and to create enhanced crops. Plant genomes can be engineered by physical methods or by use of Agrobacterium for the delivery of sequences hosted in T-DNA binary vectors. Many plant cells are pluripotent, meaning that a single cell from a mature plant can be harvested and then under the right conditions form a new plant. This ability is most often taken advantage by genetic engineers through selecting cells that can successfully be transformed into an adult plant which can then be grown into multiple new plants containing transgene in every cell through a process known as tissue culture.

<span class="mw-page-title-main">Do-it-yourself biology</span> Biotechnological social movement

Do-it-yourself biology is a biotechnological social movement in which individuals, communities, and small organizations study biology and life science using the same methods as traditional research institutions. DIY biology is primarily undertaken by individuals with limited research training from academia or corporations, who then mentor and oversee other DIY biologists with little or no formal training. This may be done as a hobby, as a not-for-profit endeavor for community learning and open-science innovation, or for profit, to start a business.

<span class="mw-page-title-main">Nathaniel David</span> American scientist and entrepreneur

Nathaniel David is an American scientist and entrepreneur who co-founded a series of technology companies in the biotechnology and sustainable energy sectors, including Syrrx, Achaogen, Kythera Biopharmaceuticals, Sapphire Energy and Unity Biotechnology. These companies have collectively raised more than $1.5 billion in financing.

Immunophysics is a novel interdisciplinary research field using immunological, biological, physical and chemical approaches to elucidate and modify immune-mediated mechanisms and to expand our knowledge on the pathomechanisms of chronic immune-mediated diseases such as arthritis, inflammatory bowel disease, asthma and chronic infections.

<span class="mw-page-title-main">History of genetic engineering</span>

Genetic engineering is the science of manipulating genetic material of an organism. The concept of genetic engineering was first proposed by Nikolay Timofeev-Ressovsky in 1934. The first artificial genetic modification accomplished using biotechnology was transgenesis, the process of transferring genes from one organism to another, first accomplished by Herbert Boyer and Stanley Cohen in 1973. It was the result of a series of advancements in techniques that allowed the direct modification of the genome. Important advances included the discovery of restriction enzymes and DNA ligases, the ability to design plasmids and technologies like polymerase chain reaction and sequencing. Transformation of the DNA into a host organism was accomplished with the invention of biolistics, Agrobacterium-mediated recombination and microinjection. The first genetically modified animal was a mouse created in 1974 by Rudolf Jaenisch. In 1976, the technology was commercialised, with the advent of genetically modified bacteria that produced somatostatin, followed by insulin in 1978. In 1983, an antibiotic resistant gene was inserted into tobacco, leading to the first genetically engineered plant. Advances followed that allowed scientists to manipulate and add genes to a variety of different organisms and induce a range of different effects. Plants were first commercialized with virus resistant tobacco released in China in 1992. The first genetically modified food was the Flavr Savr tomato marketed in 1994. By 2010, 29 countries had planted commercialized biotech crops. In 2000 a paper published in Science introduced golden rice, the first food developed with increased nutrient value.

Calico Life Sciences LLC is an American biotechnology company with a focus on the biology of aging, attempting to devise interventions that may enable people to lead longer and healthier lives. It is a subsidiary of Alphabet Inc.

<span class="mw-page-title-main">Genspace</span> Non-profit organization in Brooklyn, NY

Genspace is a non-profit organization and a community biology laboratory located in Brooklyn, New York. Stemming from the hacking, biohacking, and DIYbio movements, Genspace has focused on supporting citizen science and public access to biotechnology. Genspace opened the first community biology lab in 2010 and a Biosafety Level One laboratory in December of that year. Since its opening, Genspace has supported projects, events, courses, art, and general community resources concerning biology, biotechnology, synthetic biology, genetic engineering, citizen science, open source software, open source hardware, and more.

Ryan Bethencourt is an American scientist, entrepreneur, and biohacker best known for his work as co-founder and CEO of Wild Earth, Partner at Babel Ventures and cofounder and former Program Director at IndieBio, a biology accelerator and early stage seed fund. Bethencourt was head of life sciences at the XPRIZE foundation, a co-founder and CEO of Berkeley Biolabs, a biotech accelerator, and Halpin Neurosciences, an ALS therapeutics-focused biotech company. Bethencourt co-founded Counter Culture Labs, a citizen science nonprofit, and Sudo Room, a hacker space based in downtown Oakland, California.

Cellular agriculture focuses on the production of agricultural products from cell cultures using a combination of biotechnology, tissue engineering, molecular biology, and synthetic biology to create and design new methods of producing proteins, fats, and tissues that would otherwise come from traditional agriculture. Most of the industry is focused on animal products such as meat, milk, and eggs, produced in cell culture rather than raising and slaughtering farmed livestock which is associated with substantial global problems of detrimental environmental impacts, animal welfare, food security and human health. Cellular agriculture is a field of the biobased economy. The most well known cellular agriculture concept is cultured meat.

<span class="mw-page-title-main">Zbyszek Darzynkiewicz</span> Polish-American cell biologist (1936–2021)

ZbigniewDarzynkiewicz was a Polish-American cell biologist active in cancer research and in developing new methods in histochemistry for flow cytometry.

<span class="mw-page-title-main">Unity Biotechnology</span> American biotechnology company

Unity Biotechnology, Inc. is a publicly traded American biotechnology company that develops drugs that target senescent cells.

<span class="mw-page-title-main">Opentrons</span> Bioscience liquid handler manufacturer

Opentrons Labworks, Inc. is a biotechnology company that manufactures liquid handling robots that use open-source software, which at one point used open-source hardware but no longer does. Their robots can be used by scientists to manipulate small volumes of liquids for the purpose of undertaking biochemical or chemical reactions. Currently, they offer the OT-2 and Flex robots. These robots are used primarily by researchers and scientists interested in DIY biology, but they are increasingly being used by other biologists.

BIOTECanada, previously the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario. It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.

References

  1. "Ellen D. Jorgensen". Bio Art, SVA NYC (bioart.sva.edu).
  2. 1 2 3 4 5 "Ellen Jorgensen". Global Community Bio Summit. Archived from the original on 2018-06-19. Retrieved 2018-03-30.
  3. 1 2 3 4 "Ellen Jorgensen- THNK School of Creative Leadership". THNK. Retrieved 2018-03-30.
  4. "Biotech Without Borders - HackerspaceWiki". wiki.hackerspaces.org. Retrieved 2024-09-09.
  5. "DLD Conference: Digital-Life-Design". dld-conference.com. Retrieved 2024-09-09.
  6. "Carbon Bridge". IndieBio - #1 in Early Stage Biotech. Retrieved 2024-09-09.
  7. "Ellen Jorgensen | LinkedIn" . Retrieved 2017-03-27.
  8. 1 2 3 4 Aiolova, Maria. "ONE Lab". www.onelab.org. Archived from the original on 2019-04-02. Retrieved 2018-03-30.
  9. "Ellen D. Jorgensen – SVA Bio Art Lab". bioart.sva.edu. Retrieved 2024-09-09.
  10. 1 2 Jorgensen, Ellen. "Ellen Jorgensen | Speaker | TED" . Retrieved 2018-03-30.
  11. Techonomy. "The New Biohackers: How (And Where) They Work". Forbes. Retrieved 2024-09-09.
  12. 1 2 3 "Support Us". Genspace. Retrieved 2018-03-30.
  13. 1 2 "The World's Top 10 Most Innovative Companies In Education". Fast Company. 2014-02-13. Retrieved 2018-03-30.
  14. 1 2 3 Jorgensen, Ellen. "Transcript of "Biohacking -- you can do it, too"" . Retrieved 2018-03-30.
  15. 1 2 3 "Ellen Jorgensen stepping down as head of Genspace, Daniel Grushkin to replace - Technical.ly Brooklyn". Technical.ly Brooklyn. 2017-03-29. Retrieved 2018-03-30.
  16. "About the Lab". Genspace. Retrieved 2018-03-30.
  17. "Join the Lab". Genspace. Retrieved 2018-03-30.
  18. "Community Projects". Genspace. Retrieved 2018-03-30.
  19. "Here's who won the Brooklyn Innovation Awards last night - Technical.ly Brooklyn". Technical.ly Brooklyn. 2017-01-06. Retrieved 2018-03-30.
  20. "About Us". Biotech Without Borders. Retrieved 2018-03-30.
  21. "Our Mission And History". Biotech Without Borders. Archived from the original on 2019-01-19. Retrieved 2018-03-30.